Budesonide Global Market Report 2025

Description

Budesonide is a corticosteroid medication used to reduce inflammation in conditions such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel diseases (including Crohn's disease and ulcerative colitis), and allergic rhinitis. It functions by suppressing the immune response and reducing inflammation in the airways or digestive tract.

The primary forms of budesonide include inhalation powder, aerosols, injectable suspensions, tablets, and capsules. Inhalation budesonide powder is a corticosteroid delivered via a dry powder inhaler to reduce airway inflammation in respiratory conditions. Budesonide is distributed through hospital pharmacies, retail pharmacies, and online pharmacies and is used for various applications, including the treatment of nasal diseases, inflammatory bowel diseases, respiratory diseases, and other conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The budesonide market research report is one of a series of new reports from The Business Research Company that provides budesonide market statistics, including the budesonide industry global market size, regional shares, competitors with the budesonide market share, detailed budesonide market segments, market trends, and opportunities, and any further data you may need to thrive in the budesonide industry. This budesonide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The budesonide market size has grown strongly in recent years. It will grow from $9.72 billion in 2024 to $10.26 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the rising prevalence of respiratory diseases, increased awareness about inhaled corticosteroids, the introduction of budesonide-based combination therapies, the expansion of healthcare access and infrastructures, and the adoption of budesonide for off-label use in inflammatory bowel diseases.

The budesonide market size is expected to see strong growth in the next few years. It will grow to $12.95 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growing demand for effective treatments, development of novel drug delivery systems, increasing use of budesonide, rising geriatric population prone to asthma, and expansion of generic budesonide products. Major trends in the forecast period include the adoption of biologics and biosimilars, advancements in drug delivery systems, regulatory approvals for new formulations, the development of novel drug delivery systems, and technological development.

The forecast of 6.0% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. allergy treatment centers by increasing costs of budesonide nasal sprays imported from Germany and Sweden, potentially reducing asthma control and raising immunology treatment expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of respiratory diseases is expected to drive the growth of the budesonide market. Respiratory diseases, which impact the organs and tissues responsible for gas exchange, are increasing due to factors such as rising air pollution, exposure to particulate matter, and allergens. These environmental factors contribute significantly to conditions such as asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a corticosteroid, is commonly used to manage these respiratory diseases by reducing inflammation, improving airflow, and preventing symptoms such as wheezing and shortness of breath. For instance, according to the National Center for Health Statistics (NCHS), the prevalence of asthma among adults in the U.S. increased from 8.4% in 2021 to 8.7% in 2022, with asthma episodes rising from 3.3% to 3.7% during the same period. Consequently, the growing incidence of respiratory diseases is expected to fuel the expansion of the budesonide market.

Companies in the budesonide market are focusing on innovative oral and inhaled therapies to enhance treatment effectiveness and patient adherence. Oral formulations of budesonide provide a convenient treatment option, especially for inflammatory conditions. For example, in February 2024, Takeda Pharmaceuticals received FDA approval for EOHILIA, the first and only FDA-approved oral budesonide suspension for patients aged 11 and above with eosinophilic esophagitis (EoE). This approval was based on positive efficacy and safety data from clinical trials, demonstrating the potential of oral budesonide in expanding treatment options for respiratory and inflammatory diseases.

In March 2023, Cheplapharm Arzneimittel GmbH acquired the U.S. commercial rights for PULMICORT FLEXHALER from AstraZeneca. This acquisition allows Cheplapharm to diversify its product offerings and expand its presence in the U.S. pharmaceutical market while ensuring continued availability of PULMICORT FLEXHALER, a widely used budesonide-based asthma treatment. AstraZeneca, a UK-based biopharmaceutical company, has long been a key player in developing and marketing PULMICORT for respiratory conditions such as asthma and COPD.

Major players in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, and Shanghai Sine Promod Pharmaceutical Co. Ltd.

North America was the largest region in the budesonide market in 2024. The regions covered in budesonide report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the budesonide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The budesonide market consists of sales of nebulizer suspension, inhalers, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Budesonide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on budesonide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for budesonide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The budesonide market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Inhalation Powder; Aerosols; Injectable Suspension; Tablets And Capsules
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Application: Nose Disease Treatment; Inflammatory Bowel Disease Treatment; Respiratory Disease Treatment; Other Applications
Subsegments:
1) By Inhalation Powder: Dry Powder Inhalers (DPI); Soft Mist Inhalers (SMI)
2) By Aerosols: Metered-Dose Inhalers (MDI); Breath-Activated Inhalers
3) By Injectable Suspension: Pre-filled Syringes; Vials
4) By Tablets And Capsules: Oral Tablets; Oral Capsules
Companies Mentioned: AstraZeneca AB; Novartis AG; Takeda Pharmaceuticals Company Limited; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Sandoz AG; Aurobindo Pharma Limited; Chiesi Farmaceutici S.p.A.; Cipla Limited; Lupin Limited; Orion Corporation; Salix Pharmaceuticals Inc.; Synmosa Biopharma Corporation; Cosmo Pharmaceuticals N.V.; Skyepharma Holdings Inc.; Manus Aktteva Biopharma LLP; Cennet Biopharma Private Limited; Santarus Inc.; SiNi Pharma Private Limited; Shanghai Sine Promod Pharmaceutical Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33987u

1. Executive Summary

2. Budesonide Market Characteristics

3. Budesonide Market Trends And Strategies

4. Budesonide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Budesonide Growth Analysis And Strategic Analysis Framework

5.1. Global Budesonide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Budesonide Market Growth Rate Analysis
5.4. Global Budesonide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Budesonide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Budesonide Total Addressable Market (TAM)

6. Budesonide Market Segmentation

6.1. Global Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalation Powder
Aerosols
Injectable Suspension
Tablets And Capsules
6.2. Global Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.3. Global Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Respiratory Disease Treatment
Other Applications
6.4. Global Budesonide Market, Sub-Segmentation Of Inhalation Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dry Powder Inhalers (DPI)
Soft Mist Inhalers (SMI)
6.5. Global Budesonide Market, Sub-Segmentation Of Aerosols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metered-Dose Inhalers (MDI)
Breath-Activated Inhalers
6.6. Global Budesonide Market, Sub-Segmentation Of Injectable Suspension, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-filled Syringes
Vials
6.7. Global Budesonide Market, Sub-Segmentation Of Tablets And Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Oral Capsules

7. Budesonide Market Regional And Country Analysis

7.1. Global Budesonide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Budesonide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Budesonide Market

8.1. Asia-Pacific Budesonide Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Budesonide Market

9.1. China Budesonide Market Overview
9.2. China Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Budesonide Market

10.1. India Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Budesonide Market

11.1. Japan Budesonide Market Overview
11.2. Japan Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Budesonide Market

12.1. Australia Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Budesonide Market

13.1. Indonesia Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Budesonide Market

14.1. South Korea Budesonide Market Overview
14.2. South Korea Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Budesonide Market

15.1. Western Europe Budesonide Market Overview
15.2. Western Europe Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Budesonide Market

16.1. UK Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Budesonide Market

17.1. Germany Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Budesonide Market

18.1. France Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Budesonide Market

19.1. Italy Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Budesonide Market

20.1. Spain Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Budesonide Market

21.1. Eastern Europe Budesonide Market Overview
21.2. Eastern Europe Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Budesonide Market

22.1. Russia Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Budesonide Market

23.1. North America Budesonide Market Overview
23.2. North America Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Budesonide Market

24.1. USA Budesonide Market Overview
24.2. USA Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Budesonide Market

25.1. Canada Budesonide Market Overview
25.2. Canada Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Budesonide Market

26.1. South America Budesonide Market Overview
26.2. South America Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Budesonide Market

27.1. Brazil Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Budesonide Market

28.1. Middle East Budesonide Market Overview
28.2. Middle East Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Budesonide Market

29.1. Africa Budesonide Market Overview
29.2. Africa Budesonide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Budesonide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Budesonide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Budesonide Market Competitive Landscape And Company Profiles

30.1. Budesonide Market Competitive Landscape
30.2. Budesonide Market Company Profiles
- 30.2.1. AstraZeneca AB Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Takeda Pharmaceuticals Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Budesonide Market Other Major And Innovative Companies

31.1. Sandoz AG
31.2. Aurobindo Pharma Limited
31.3. Chiesi Farmaceutici S.p.A.
31.4. Cipla Limited
31.5. Lupin Limited
31.6. Orion Corporation
31.7. Salix Pharmaceuticals Inc.
31.8. Synmosa Biopharma Corporation
31.9. Cosmo Pharmaceuticals N.V.
31.10. Skyepharma Holdings Inc.
31.11. Manus Aktteva Biopharma LLP
31.12. Cennet Biopharma Private Limited
31.13. Santarus Inc.
31.14. SiNi Pharma Private Limited
31.15. Shanghai Sine Promod Pharmaceutical Co. Ltd.

32. Global Budesonide Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Budesonide Market

34. Recent Developments In The Budesonide Market

35. Budesonide Market High Potential Countries, Segments and Strategies

35.1 Budesonide Market In 2029 - Countries Offering Most New Opportunities
35.2 Budesonide Market In 2029 - Segments Offering Most New Opportunities
35.3 Budesonide Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer